Multiple Sclerosis Journal - October 2017 - 1515

JMA Wijnands, E Kingwell et al.
multiple sclerosis exacerbations. Brain 2002; 125:
952-960.
3. Montgomery S, Hillert J and Bahmanyar S. Hospital
admission due to infections in multiple sclerosis
patients. Eur J Neurol 2013; 20: 1153-1160.
4. Nelson RE, Xie Y, DuVall SL, et al. Multiple sclerosis
and risk of infection-related hospitalization and death
in US veterans. Int J MS Care 2015; 17: 221-230.
5. Manouchehrinia A, Tanasescu R, Tench CR, et al.
Mortality in multiple sclerosis: Meta-analysis of
standardised mortality ratios. J Neurol Neurosurg
Psychiatry 2015; 87: 324-331.
6. Marrie RA, Elliott L, Marriott J, et al. Dramatically
changing rates and reasons for hospitalization in
multiple sclerosis. Neurology 2014; 83: 929-937.
7. BC Ministry of Health [creator] (2016): PharmaNet.
BC Ministry of Health [publisher] Data Extract Data
Stewardship Committee (2015). http://www.popdata.
bc.ca/data
8. British Columbia Ministry of Health [creator] (2015):
Medical Services Plan (MSP) Payment Information
File. Population Data BC [publisher] Data Extract
MOH (2015). http://www.popdata.bc.ca/data
9. Canadian Institute for Health Information [creator]
(2015): Discharge Abstract Database (Hospital
Separations). Population Data BC [publisher] Data
Extract MOH (2015). http://www.popdata.bc.ca/data
10. British Columbia Ministry of Health [creator] (2015):
Consolidation File (MSP Registration & Premium
Billing). Population Data BC [publisher] Data
Extract MOH (2015). http://www.popdata.bc.ca/data
11. Wilkins R. PCCF + version 5E user's guide.
Automated geographic coding based on the statistics
Canada postal code conversion files, including postal
codes through March 2009 (Catalogue 82F0086XDB2009) Statistics Canada, 2009.
12. British Columbia Vital Statistics Agency [creator]
(2015): Vital Statistics Deaths Population Data BC
[publisher] Data Extract BC Vital Statistics Agency
(2015). http://www.popdata.bc.ca/data
13. Marrie RA, Yu N, Blanchard J, et al. The rising
prevalence and changing age distribution of multiple
sclerosis in Manitoba. Neurology 2010; 74: 465-471.
14. Lacaille D, Guh DP, Abrahamowicz M, et al. Use of
nonbiologic disease-modifying antirheumatic drugs
and risk of infection in patients with rheumatoid
arthritis. Arthritis Rheum 2008; 59: 1074-1081.
15. Chang LY, Lai CC, Chen CJ, et al. Recent trends in
prescribing antibiotics for acute tonsillitis in pediatric
ambulatory care in Taiwan, 2000-2009: A nationwide
population-based study. J Microbiol Immunol
Infect. Epub ahead of print 9 September 2015. DOI:
10.1016/j.jmii.2015.08.021.

journals.sagepub.com/home/msj

16. Everhart JE. Gastrointestinal infections. In: US
Department of Health and Human Services, Public
Health Service; National Institutes of Health and
National Institute of Diabetes and Digestive and
Kidney Diseases (eds) The burden of digestive
diseases in the United States. Washington, DC: US
Government Printing Office, 2008, pp. 9-12.
17. Mueller EL, Walkovich KJ, Mody R, et al. Hospital
discharges for fever and neutropenia in pediatric
cancer patients: United States, 2009. BMC Cancer
2015; 15: 388.
18. Wang EE, Einarson TR, Kellner JD, et al. Antibiotic
prescribing for Canadian preschool children:
Evidence of overprescribing for viral respiratory
infections. Clin Infect Dis 1999; 29: 155-160.
19. Marrie RA, Cohen J, Stuve O, et al. A systematic
review of the incidence and prevalence of
comorbidity in multiple sclerosis: Overview. Mult
Scler 2015; 21: 263-281.
20. Doran MF, Crowson CS, Pond GR, et al. Frequency
of infection in patients with rheumatoid arthritis
compared with controls: A population-based study.
Arthritis Rheum 2002; 46: 2287-2293.
21. Muller LM, Gorter KJ, Hak E, et al. Increased risk
of common infections in patients with type 1 and
type 2 diabetes mellitus. Clin Infect Dis 2005; 41:
281-288.
22. Sethi S. Infection as a comorbidity of COPD. Eur
Respir J 2010; 35: 1209-1215.
23. Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk
factors for opportunistic infections in patients with
inflammatory bowel disease. Gastroenterology 2008;
134: 929-936.
24. Wakkee M, de Vries E, van den Haak P, et al.
Increased risk of infectious disease requiring
hospitalization among patients with psoriasis: A
population-based cohort. J Am Acad Dermatol 2011;
65: 1135-1144.
25. Marrie RA, Yu BN, Leung S, et al. Prevalence and
incidence of ischemic heart disease in multiple
sclerosis: A population-based validation study. Mult
Scler Relat Disord 2013; 2: 355-361.
26. Marrie RA, Yu BN, Leung S, et al. Rising prevalence
of vascular comorbidities in multiple sclerosis:
Validation of administrative definitions for diabetes,
hypertension, and hyperlipidemia. Mult Scler 2012;
18: 1310-1319.
27. Marrie RA, Yu BN, Leung S, et al. The utility of
administrative data for surveillance of comorbidity
in multiple sclerosis: A validation study.
Neuroepidemiology 2013; 40: 85-92.
28. Solomon DH, Massarotti E, Garg R, et al. Association
between disease-modifying antirheumatic drugs and

1515
http://www.popdata.bc.ca/data http://www.popdata.bc.ca/data http://www.popdata.bc.ca/data http://www.popdata.bc.ca/data http://www.popdata.bc.ca/data http://www.popdata.bc.ca/data https://journals.sagepub.com/home/msj
Table of Contents for the Digital Edition of Multiple Sclerosis Journal - October 2017
